Abstract
Diabetes mellitus is one of the most widespread chronic endocrine diseases in the world. Hypoglycemic drugs play a major role in the treatment of this disease. This article analyzes the pharmacological groups of drugs used in the treatment of diabetes mellitus and their assortment in the pharmaceutical market of Uzbekistan. According to the results of the study, insulin preparations, biguanides, sulfonylurea derivatives, α-glucosidase inhibitors, DPP-4 inhibitors, and SGLT-2 inhibitors are widely represented in the pharmacy market of the republic.